SynBiosys®: Advancing the Next Generation of Long-Acting Peptide and Protein Therapies

Session details:

With growing pharmaceutical investment in long-acting injectable technologies for obesity, diabetes, and other chronic diseases, the ability to enable sustained and predictable delivery of peptides and proteins has become a strategic priority. Discover how Innocore's SynBiosys® microsphere platform enables controlled release, high drug loading, and formulation flexibility across a broad range of peptide and protein therapeutics.